Genetic variation unlikely to influence COVID-19 morbidity and mortality
UofA lab uncovers new mechanism of action against SARS-CoV-2 by antiviral drug remdesivir
Fujifilm’s Avigan shown to be effective in Japanese Phase 3 trial for Covid-19
Fujifilm’s Avigan shown to be effective in Japanese Phase-3 trial for Covid-19
Faulty transportation of messenger RNA is the culprit in ALS
3 "Strong Buy" Stocks That Are Flirting With a Bottom
A cheaper, faster COVID-19 test
Scoop: ARCH’s Bob Nelsen is backing an mRNA upstart that promises to upend the entire manufacturing side of the global business
How and when will we know that a COVID-19 vaccine is safe and effective?
New drug candidate found for hand, foot and mouth disease
Lies, Damned Lies, & UK Health Statistics: The Deadly Danger Of False Positives
CRISPR-based malaria testing on-the-fly
Controversy Aside, Why the Source of COVID-19 Matters
PNNL, UW broaden capacity to test for COVID-19
Moderna Publishes COVID-19 Vaccine Trial "Blueprint" To Quiet Concerns About Rushed Approval
Keeping coronavirus vaccines at subzero temperatures during distribution will be hard, but likely key to ending pandemic
Silicon Valley startup Visby’s portable Covid-19 test gets FDA approval
12 Steps To Create Your Own Pandemic
Jennifer Doudna sees CRISPR gene-editing tech as a Swiss Army knife for COVID-19 and beyond
Rapid test for Covid-19 shows improved sensitivity
Biomarker predicts who will have severe COVID-19
BioNTech Buys German Site From Novartis To Boost Covid-19 Vaccine Supply
Lilly’s antibody therapy cuts hospitalisation rates in COVID-19
BioNTech, CureVac claim bulk of Germany’s €750m COVID-19 vaccines fund
Oppenheimer: 3 Stocks That Could Surge Over 100% From Current Levels
Beyond the Spike: The COVAXX Approach to a COVID-19 Vaccine
Smart virus
Pfizer, BioNTech propose expanding CovidD-19 vaccine trial to 44,000 volunteers
Lab-on-paper strip: Small, inexpensive platform for diagnosing tropical fevers
A primer on viruses, vaccines, and therapies